首页> 美国卫生研究院文献>OncoTargets and therapy >Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells
【2h】

Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells

机译:AURKA蛋白激酶在三阴性乳腺癌干细胞中形成血管生成拟态的功能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor cell vasculogenic mimicry (VM), a newly defined pattern of tumor blood supply, signifies the functional plasticity of aggressive cancer cells forming vascular networks. VM and cancer stem cells (CSCs) have been shown to be associated with tumor growth, local invasion, and distant metastasis. In our previous study, CSCs in triple-negative breast cancer were potential to participate in VM formation. In this study, breast CSCs were isolated from the triple-negative breast cancer cell line MDA-MB-231 by using mammosphere culture. Western blotting and reverse transcription polymerase chain reaction showed that mammosphere cells displayed an increased expression of AURKA protein kinase and stem cell marker c-myc and sox2. The VM formation by mammosphere cells was inhibited by AURKA knockdown or the addition of AURKA inhibitor MLN8237. In the meantime, MLN8237 induced the increased E-cadherin and decreased c-myc, sox2, and β-catenin expressions. The function of AURKA in VM formation was further confirmed using a xenograft-murine model. The results suggested that AURKA protein kinase is involved in VM formation of CSCs and may become a new treatment target in suppressing VM and metastasis of breast cancer.
机译:肿瘤细胞血管生成模拟物(VM)是一种新定义的肿瘤血液供应模式,表明形成血管网络的侵袭性癌细胞的功能可塑性。 VM和癌症干细胞(CSC)已被证明与肿瘤生长,局部浸润和远处转移有关。在我们之前的研究中,三阴性乳腺癌中的CSCs可能参与VM的形成。在这项研究中,通过乳腺球培养从三阴性乳腺癌细胞系MDA-MB-231中分离出乳腺CSC。 Western印迹和逆转录聚合酶链反应表明,哺乳动物细胞显示AURKA蛋白激酶和干细胞标志物c-myc和sox2的表达增加。通过AURKA抑制或添加AURKA抑制剂MLN8237抑制了乳球细胞的VM形成。同时,MLN8237诱导E-钙粘蛋白增加,而c-myc,sox2和β-catenin表达下降。使用异种移植-鼠模型进一步证实了AURKA在VM形成中的功能。结果提示,AURKA蛋白激酶参与了CSCs VM的形成,可能成为抑制乳腺癌VM和转移的新治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号